PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
17.97%
Positive EBIT growth while RVPH is negative. John Neff might see a substantial edge in operational management.
17.97%
Positive operating income growth while RVPH is negative. John Neff might view this as a competitive edge in operations.
18.43%
Positive net income growth while RVPH is negative. John Neff might see a big relative performance advantage.
58.16%
Positive EPS growth while RVPH is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
58.16%
Positive diluted EPS growth while RVPH is negative. John Neff might view this as a strong relative advantage in controlling dilution.
96.23%
Share change of 96.23% while RVPH is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
96.23%
Diluted share change of 96.23% while RVPH is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
22.94%
Positive OCF growth while RVPH is negative. John Neff would see this as a clear operational advantage vs. the competitor.
22.94%
Positive FCF growth while RVPH is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-567.72%
Negative 10Y OCF/share CAGR while RVPH stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
90.81%
OCF/share CAGR of 90.81% while RVPH is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
89.23%
3Y OCF/share CAGR of 89.23% while RVPH is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
-636.46%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
93.35%
Positive 5Y CAGR while RVPH is negative. John Neff might view this as a strong mid-term relative advantage.
88.82%
Positive short-term CAGR while RVPH is negative. John Neff would see a clear advantage in near-term profit trajectory.
2271.09%
Equity/share CAGR of 2271.09% while RVPH is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-76.58%
Negative 5Y equity/share growth while RVPH is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-2.44%
Negative 3Y equity/share growth while RVPH is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
569.03%
Asset growth well under 50% of RVPH's 17289.84%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
756.79%
1.25-1.5x RVPH's 552.61%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-16.19%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-15.49%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-24.67%
We cut SG&A while RVPH invests at 113.50%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.